Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
-1.68%
3-Month Return
-2.92%
12-Month Return
+32.44%
Volatility Score
1.9
RSI
44.4
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $178B | +20.96% | -2.86% | -6.64% | 2.6 | Down | Neutral |
| GILD | Gilead Sciences | $163B | +30.35% | -6.73% | -6.17% | 2.3 | Down | Up |
| VRTX | Vertex Pharma | $108B | -15.41% | -9.79% | -5.22% | 2.2 | Down | Down |
| REGN | Regeneron Pharma | $74B | +16.45% | -5.29% | -9.76% | 2.9 | Down | Neutral |
| ARGX | arGEN-X SpADR | $49B | +20.60% | -6.78% | +5.43% | 2.6 | Up | Neutral |
| ALNY | Alnylam Pharma | $40B | +14.16% | -12.41% | -9.92% | 4.3 | Down | Down |
| ONC | BeOne Medi Sp ADR | $33B | +14.89% | -13.67% | -4.73% | 2.6 | Down | Down |
| RVMD | REVOLUTION MEDIC | $30B | +242.53% | +43.87% | +41.40% | 6.2 | Up | Up |
| NTRA | Natera | $30B | +32.31% | -10.32% | +2.00% | 5.1 | Neutral | Up |
| INSM | Insmed | $29B | +84.32% | -15.05% | -19.17% | 3.9 | Down | Down |
| BIIB | Biogen | $28B | +51.43% | +3.99% | +1.78% | 3.2 | Neutral | Up |
| BNTX | BioNTech Sp ADR | $25B | -7.05% | -14.25% | +9.08% | 3.9 | Down | Down |
| UTHR | United Therapeut | $24B | +93.62% | +21.49% | +0.02% | 2.4 | Up | Up |
| ILMN | Illumina | $21B | +74.35% | -6.24% | +7.23% | 4.0 | Up | Up |
| ROIV | ROIVANT SCIENCES | $20B | +142.42% | +28.72% | -0.04% | 3.4 | Down | Up |
| INCY | Incyte | $19B | +54.98% | -3.16% | +2.77% | 3.1 | Neutral | Up |
| MRNA | MODERNA | $18B | +64.32% | +2.95% | -9.31% | 6.0 | Down | Up |
| GMAB | GENMAB SP ADR | $16B | +23.14% | -18.94% | -2.83% | 2.8 | Down | Down |
| ASND | Ascendis Sp ADR | $14B | +28.40% | -2.29% | -3.20% | 3.9 | Down | Up |
| BBIO | BRIDGEBIO PHARMA | $13B | +77.75% | -11.27% | -7.91% | 5.2 | Down | Up |
| NBIX | Neurocrine Biosc | $13B | +20.15% | -3.15% | -0.59% | 3.0 | Neutral | Down |
| SMMT | SUMMIT THERAP | $13B | -42.24% | +11.29% | -14.83% | 11.2 | Down | Down |
| IONS | Ionis Pharmaceut | $12B | +129.65% | -8.94% | +0.20% | 3.1 | Down | Up |
| MEDP | Medpace Holdings | $12B | +36.85% | -28.32% | -14.70% | 5.6 | Down | Down |
| MDGL | Madrigal Pharmct | $12B | +62.84% | +4.99% | -3.04% | 3.4 | Up | Up |
| EXEL | Exelixis | $11B | +10.30% | +5.61% | -0.82% | 3.0 | Neutral | Up |
| AXSM | Axsome Therapeut | $11B | +84.06% | +12.09% | +20.23% | 3.7 | Up | Up |
| ARWR | Arrowhead Phrmct | $10B | +418.79% | +7.90% | +18.90% | 4.2 | Up | Up |
| BMRN | Biomarin Pharm | $10B | -12.85% | -4.39% | -5.56% | 2.5 | Down | Down |
| TEM | TEMPUS AI-A | $9.9B | -3.61% | -8.06% | +16.95% | 6.3 | Up | Down |
| ABVX | ABIVAX SP ADS | $9.3B | +1535.74% | +5.81% | +2.30% | 4.7 | Neutral | Up |
| PRAX | PRAXIS PRECIS | $9B | +705.67% | +3.25% | +1.54% | 5.7 | Neutral | Up |
| TECH | Bio-Techne | $8.6B | +9.61% | -14.04% | +2.88% | 4.9 | Neutral | Down |
| PCVX | VAXCYTE | $8.2B | +60.86% | +6.27% | -2.68% | 3.8 | Down | Up |
| CRL | Charles Riv Lab | $8.2B | +39.95% | -21.24% | -5.21% | 4.4 | Down | Down |
| CYTK | Cytokinetics | $7.9B | +69.61% | +0.25% | -4.89% | 3.7 | Down | Up |
| KRYS | KRYSTAL BIOTECH | $7.8B | +60.11% | -4.73% | +2.75% | 3.4 | Neutral | Up |
| NUVL | NUVALENT-A | $7.8B | +27.86% | -3.74% | -6.25% | 3.6 | Down | Up |
| HALO | Halozyme Therape | $7.6B | +4.53% | -10.81% | -2.20% | 3.1 | Down | Down |
| IBRX | IMMUNITYBIO | $7.4B | +179.92% | +13.76% | -0.42% | 7.2 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |